About: R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL (en) R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL (nl)
skos:prefLabel	R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL (en) R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL (nl)
name	R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL (en) R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL (nl)
title	wds:Q66070474-CAE87822-DCE8-4B7C-98D9-787858C3426E
title	A Multicenter,Randomized, Controlled (Comparative), Open, Prospective Study Evaluating an Efficacy of R-DA-EPOCH and R-CEOP90, With or Without Upfront Auto-HSCT，in Newly Diagnosed Young Patients With Intermediate/High-risk DLBCL (en)
end time	wds:Q66070474-CDF1F2D2-BD44-4077-9BFB-0EFB9D22B586
end time	2019-02-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q66070474-B1EAA9DB-DB58-4414-AB5A-712259A08A60
instance of	clinical trial
start time	wds:Q66070474-97B2B376-D824-45AE-A405-AC18F201132F
start time	2017-02-01 00:00:00Z (xsd:dateTime)
research site	wds:Q66070474-86DCF4D0-34A2-401C-BAB4-684EAAE5C37B
research site	Union Hospital
research intervention	wds:Q66070474-8833166A-6E66-4377-A73F-47A16BFAB01A wds:Q66070474-B1CA115F-1E44-48EA-A346-CEFA75BA83B0 wds:Q66070474-D7966663-209B-416D-A2D0-A3D8FF6B7370
research intervention	(RS)-cyclophosphamide wd:Q18936 prednisone
minimum age	wds:Q66070474-37B5D20D-F86B-40F2-86CF-BAF6BAB9B6BA
minimum age	16 (xsd:decimal)
number of participants	wds:Q66070474-F987702E-B3B1-4E4D-AF40-A0BC26793152
number of participants	475 (xsd:decimal)
maximum age	wds:Q66070474-C61ADC00-EA69-4CF5-8A87-FA437B524945
maximum age	60 (xsd:decimal)
study type	wds:Q66070474-40E1B7F2-6BF0-467C-AA8A-A72BB016CF1E
study type	interventional study
ClinicalTrials.gov ID	wds:Q66070474-69F03890-D57E-4EBD-885F-F1B39FFDDD6A
ClinicalTrials.gov ID	NCT03213977
clinical trial phase	wds:Q66070474-B2F2045E-D082-44A4-90C0-EAE1E1831B7C
clinical trial phase	phase III clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66070474

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software